Alaunos Therapeutics Inc
(STU:WEK)
€
1.66
0 (-4.82%)
Market Cap: 338.23 Mil
Enterprise Value: 276.94 Mil
PE Ratio: 0
PB Ratio: 1.04
GF Score: 54/100 
ZIOPHARM Oncology Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 14, 2020 / 09:00PM GMT
Release Date Price:
€2.44
(-6.87%)
Olivia Brayer;BofA Merrill Lynch;Analyst
Research Division
Great. So good afternoon, everyone, and welcome to our afternoon session of the BofA Virtual Las Vegas Healthcare Conference. My name is Olivia Brayer, and I'm on the U.S. biopharma team here at Bank of America. And we're very happy to have with us on the line the Chief Executive Officer of Ziopharm Oncology, Laurence Cooper; as well as President, David Mauney; and Chief Financial Officer, Sath Shukla. Guys, are you all there?
Laurence James Neil Cooper
ZIOPHARM Oncology, Inc. - CEO & Director
We are, Olivia. Thank you so much, and welcome.
David M. Mauney
ZIOPHARM Oncology, Inc. - President
Yes. We're here. Thank you.
Questions & Answers
Olivia Brayer;BofA Merrill Lynch;Analyst
Research Division
All right. Perfect. Great. So with that, I'll just dive right in. So Laurence, on a COVID-19 front, obviously, coronavirus has
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers